Castle Biosciences, Inc. (CSTL) at a glance

Castle Biosciences, Inc. (CSTL) is a small-cap Healthcare company. It trades at $33.24, with a P/E of 30.5, a -3.8% profit margin and revenue decline of 4.9%. It does not pay a dividend. Vestovix scores it 40/100 overall. Its strongest dimension is Momentum (56/100) and its weakest is Value (33/100). Its volatility is roughly in line with the market.

Price

$33.24

Market cap

$627.8M

P/E ratio

30.5

Dividend yield

None

Beta

1.02

52-week range

$17.72 to $44.28